The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors
- PMID: 1979159
The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors
Abstract
We have compared the effects of the v-erb A oncogene on proliferation and differentiation of normal erythroid progenitors with those of tyrosine kinase oncogenes, e.g. v-sea. For this, a v-erb A retrovirus containing the neomycin resistance gene as a selectable marker or, alternatively, a v-erb A-ts v-sea retrovirus were used to infect normal bone marrow cells. V-erb A induced the outgrowth of immature, erythropoietin(EPO)-dependent erythroid cells from infected bone marrow which ceased to proliferate and disintegrated after 9 to 18 divisions. In contrast, ts-v-sea erythroblasts grew for the expected 25 to 40 population doublings in the absence of EPO. Transcription of the erythrocyte genes carbonic anhydrase II and erythrocyte anion transporter was significantly inhibited in v-erb A infected erythroblasts, indicating that v-erb A alone was sufficient for the repression of the erythrocyte-specific genes observed in AEV-transformed leukemic cells. A detailed analysis of the differentiation phenotype induced by v-erb A in erythroblasts (in the presence or absence of a temperature-inactivated ts sea oncogene) indicates that v-erb A-erythroblasts express a partially mature, aberrant phenotype characterized by the coexpression of mature and immature differentiation antigens. This phenotype clearly differs from that induced by tyrosine kinase oncogenes in erythroid cells.
Similar articles
-
The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation.Oncogene. 1992 Oct;7(10):1903-11. Oncogene. 1992. PMID: 1408132
-
Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.Oncogene. 1992 Feb;7(2):217-27. Oncogene. 1992. PMID: 1347914
-
Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B.Oncogene. 1990 Aug;5(8):1125-31. Oncogene. 1990. PMID: 2168027
-
The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?Cancer Surv. 1992;14:169-80. Cancer Surv. 1992. PMID: 1358441 Review.
-
The erythroid island: structure and function.Pathobiol Annu. 1977;7:63-81. Pathobiol Annu. 1977. PMID: 339154 Review. No abstract available.
Cited by
-
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.EMBO J. 1993 Apr;12(4):1343-54. doi: 10.1002/j.1460-2075.1993.tb05779.x. EMBO J. 1993. PMID: 8096810 Free PMC article.
-
Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.EMBO J. 1992 Sep;11(9):3355-65. doi: 10.1002/j.1460-2075.1992.tb05414.x. EMBO J. 1992. PMID: 1354613 Free PMC article.
-
Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10668-72. doi: 10.1073/pnas.90.22.10668. Proc Natl Acad Sci U S A. 1993. PMID: 7902566 Free PMC article.
-
The estrogen receptor cooperates with the TGF alpha receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal.EMBO J. 1993 Mar;12(3):951-60. doi: 10.1002/j.1460-2075.1993.tb05736.x. EMBO J. 1993. PMID: 8458346 Free PMC article.
-
Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses.Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10633-7. doi: 10.1073/pnas.89.22.10633. Proc Natl Acad Sci U S A. 1992. PMID: 1359543 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials